A new family of potent TLR9 agonists, EnanDIM, which inhibit tumor growth in various syngeneic murine models

Publication date: March 2018
Source:European Journal of Cancer, Volume 92, Supplement 1
Author(s): B. Volz, K. Kapp, D. Oswald, B. Wittig, M. Schmidt




http://ift.tt/2IuMikm